Willert RP, Lawrance IC. Use of infliximab in the prevention and delay of colectomy in severe steroid dependant and refractory ulcerative colitis. World J Gastroenterol 2008; 14(16): 2544-2549 [PMID: 18442203 DOI: 10.3748/wjg.14.2544]
Corresponding Author of This Article
Ian Craig Lawrance, Associate Professor of Medicine, Director of the Centre for Inflammatory Bowel Diseases, The School of Medicine and Pharmacology, University of Western Australia, T Block Fremantle Hospital, Alma Street, Fremantle 6059, WA, Australia. ilawranc@cyllene.uwa.edu.au
Article-Type of This Article
Rapid Communication
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/